
by Proscia
Concentriq is Proscia's pathology AI platform for labs and life sciences teams, covering work from biomarker research to clinical case review. Proscia says it is used by 16 of the top 20 pharmaceutical companies and more than 4,000 hospitals and clinics.
Web appContact for pricing
Step 1: Decide whether your use is clinical review or life sciences research, since Proscia offers separate solutions for each.
Step 2: Explore the Concentriq portfolio on Proscia's site and pick the configuration that matches your regulatory needs.
Step 3: Contact Proscia to see the platform in action.
Step 4: Digitize your slides and bring cases into Concentriq.
Step 5: Review cases and run supported AI applications on them.
Concentriq is Proscia's pathology AI platform, used from biomarker discovery and clinical trials through diagnostic case review.
Only one configuration, Concentriq AP-Dx, is cleared for primary clinical diagnosis. The other configurations are for research use only.
Proscia says 16 of the top 20 pharmaceutical companies and more than 4,000 hospitals and clinics worldwide use it.
Proscia's site announces that Agilent is to acquire the company.
Ibex GalenIbex Galen applies AI to AI pathology platform for detecting cancer and supporting pathologists during digital slide review.
Annalise.aiAnnalise.ai applies AI to AI radiology decision-support platform for detecting and prioritizing findings on medical images.